e-Edition
Obituaries
Photo Gallery
Magazines
News Crew
Paywall Login
Login to Comment
Register
December 15th, 2015
Menu
Home
News
Sports
Business
Entertainment
Federal Election
Classifieds
Life
Commentary
Contact
Local News
Provincial News
National News
World News
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Biogen, Inc.
(NQ:
BIIB
)
269.44
USD
-0.68 (-0.25%)
Official Closing Price
Updated: 7:56 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Biogen, Inc.
< Previous
1
2
...
47
48
49
50
51
52
53
54
55
...
57
58
Next >
XplosiveStocks.com: BIIB, CECO, HPQ, BAC, JNJ, WFC Hot Stock Alerts!
February 06, 2009
From
PR Newswire
Biogen Idec Reports Full Year and Fourth Quarter 2008 Results
February 05, 2009
From
Business Wire News Releases
Biogen Idec Receives Shareholder Proposal
February 05, 2009
From
Business Wire News Releases
Dyax Announces Expansion of Antibody Discovery Collaboration with Biogen Idec
February 05, 2009
From
Business Wire News Releases
XplosiveStocks.com: PDGI, ITMN, ERIC, NVDA, RCII, BIIB Hot Stock Alerts!
February 03, 2009
From
PR Newswire
Seven Summits Research Releases Comments on AXP, PBR, BIIB, ISRG, and GERN
January 23, 2009
From
PR Newswire
Zacks Releases Four Powerful ''Buy'' Stocks: Biogen Idec, NTELOS Holdings Corp., Northwestern Corp. and IDACORP
January 20, 2009
From
Business Wire News Releases
Biogen Idec to Report Fourth Quarter and Full Year 2008 Financial Results on February 6, 2009
January 09, 2009
From
Business Wire News Releases
Biogen Idec to Present at the 27th Annual J.P. Morgan Healthcare Conference
January 06, 2009
From
Business Wire News Releases
BridgewaterEquity.com Free Fundamental Sector & Market Research on SNDA, BIIB, PFCB and EBAY
January 06, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Bridgewater Equity (BWE).
From
Marketwired News Releases
Biogen Idec to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
January 05, 2009
From
Business Wire News Releases
Seven Summits Research Releases Comments on T, ICE, SNDK, NOC, and BIIB
January 05, 2009
From
PR Newswire
Beacon Equity Issues Technical Trade Alerts on Market Movers: ARTC, GOOG, FSLR, TEVA, COST, BIIB
December 22, 2008
From
PR Newswire
Phase III Study Showed Rituxan® Decreased the Progression of Joint Damage in Patients with Early Rheumatoid Arthritis (RA)
December 18, 2008
From
Business Wire News Releases
Zacks Analyst Blog Highlights: Canadian Pacific Railway Limited, Biogen Idec Inc., Plexus Corp., The Dow Chemical Company, and Jones Lang LaSalle, Incorporated
December 16, 2008
From
Business Wire News Releases
BenchmarkJournal.com (Complimentary) Analyst Review for SWKS, PTEN, BIIB and AKAM
December 11, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Benchmark Journal.
From
Marketwired News Releases
Rituxan in Combination with Chemotherapy Improves Progression-Free Survival in Difficult-to-Treat Form of Blood Cancer
December 06, 2008
From
Business Wire News Releases
Biovitrum's and Syntonix's Novel Factor IXFc for Hemophilia B has Received Orphan Drug Designation From the FDA
November 24, 2008
From
Marketwired News Releases
Biogen Idec to Present at the Lazard Capital Markets Fifth Annual Life Sciences Conference
November 14, 2008
From
Business Wire News Releases
Biogen Idec to Present at the Credit Suisse 2008 Healthcare Conference
November 07, 2008
From
Business Wire News Releases
Biogen Idec Elects to Participate with Genentech in the Development and Commercialization of a Next Generation Anti-CD20 Molecule
October 30, 2008
From
Business Wire News Releases
Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: CPO, CHH, PHM, BIIB, AVP, SLAB
October 29, 2008
From
PR Newswire
Biogen Idec to Present at the Oppenheimer 19th Annual Healthcare Conference
October 28, 2008
From
Business Wire News Releases
Rituxan Data in Patients with Rheumatoid Arthritis to Be Presented at the American College of Rheumatology Annual Scientific Meeting
October 27, 2008
From
Business Wire News Releases
Phase IIb Data Published in the Lancet Show That BG-12, Biogen Idec's Novel Oral Compound, Significantly Reduced Brain Lesions in Patients with Multiple Sclerosis
October 23, 2008
From
Business Wire News Releases
Zacks Analyst Blog Highlights: Peabody Energy Corp., Pfizer Inc., SanDisk Corp., Everest Re Group, Ltd. and Biogen Idec Inc.
October 22, 2008
From
Business Wire News Releases
Biogen Idec Reports Third Quarter 2008 Results
October 21, 2008
38% Revenue Growth
From
Business Wire News Releases
BellwetherReport.com Analyst Opinions on BIIB, EGLE, SNV and LMT
October 15, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report.
From
Marketwired News Releases
Zacks Analyst Blog Highlights: Biogen Idec, Inc., Royal Bank of Scotland Group Plc., Lloyds TSB Group Plc., HBOS Plc. and Strayer Education, Inc.
October 13, 2008
From
Business Wire News Releases
Biogen Idec Announces Top-Line Results from Phase II Clinical Trial of Baminercept in Rheumatoid Arthritis
October 09, 2008
From
Business Wire News Releases
< Previous
1
2
...
47
48
49
50
51
52
53
54
55
...
57
58
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.